Half-year report · HY

Period2025-04-01 → 2025-09-30
Filed2025-11-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥17.9bn2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥39.4bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥20.2bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income−¥557m2025-04-01 → 2025-09-30Cons.Operating income
Operating income¥2.5bn2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income¥531m2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥1.9bn2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.4bn2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax¥361m2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax¥2.4bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)¥229m2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.2bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.9bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income¥229m2025-04-01 → 2025-09-30Cons.Profit loss
Net income¥1.9bn2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥81.9bnat 2025-09-30Cons.Assets
Total assets¥83.9bnat 2025-03-31Cons.Assets
Total assets¥84.4bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥9.7bnat 2025-09-30Cons.Liabilities
Total liabilities¥10.7bnat 2025-03-31Cons.Liabilities
Net assets / equity¥72.2bnat 2025-09-30Cons.Net assets
Net assets / equity¥73.2bnat 2025-03-31Cons.Net assets
Net assets / equity¥75.3bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥9.1bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥15.1bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥12.3bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥18.3bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥19.8bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥18.7bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow−¥1.3bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥4.4bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥3.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥3.6bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥3.5bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥838m2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.6bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥732m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥4.212025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥22.252024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥35.392024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio88.2%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio87.3%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio89.2%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
LALreportable segmentrevenue2025-04-01 → 2025-09-30¥5.8bn
LALreportable segmentrevenue external2025-04-01 → 2025-09-30¥5.8bn
LALreportable segmentsegment profit2025-04-01 → 2025-09-30¥178m
Pharmaceuticalreportable segmentrevenue2025-04-01 → 2025-09-30¥12.1bn
Pharmaceuticalreportable segmentrevenue external2025-04-01 → 2025-09-30¥12.1bn
Pharmaceuticalreportable segmentsegment profit2025-04-01 → 2025-09-30−¥735m
—segment totalrevenue2025-04-01 → 2025-09-30¥17.9bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥17.9bn
—segment totalsegment profit2025-04-01 → 2025-09-30−¥557m
LALreportable segmentrevenue2024-04-01 → 2024-09-30¥5.9bn
LALreportable segmentrevenue external2024-04-01 → 2024-09-30¥5.9bn
LALreportable segmentsegment profit2024-04-01 → 2024-09-30¥481m
Pharmaceuticalreportable segmentrevenue2024-04-01 → 2024-09-30¥14.3bn
Pharmaceuticalreportable segmentrevenue external2024-04-01 → 2024-09-30¥14.3bn
Pharmaceuticalreportable segmentsegment profit2024-04-01 → 2024-09-30¥2.1bn
—segment totalrevenue2024-04-01 → 2024-09-30¥20.2bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥20.2bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥2.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 528
ItemContextValueUnit
Raw materials and suppliesPrior1YearInstant2906000000JPY
Raw materials and suppliesInterimInstant2793000000JPY
Other caPrior1YearInstant3516000000JPY
Other caInterimInstant4536000000JPY
Allowance for doubtful accounts caPrior1YearInstant-53000000JPY
Allowance for doubtful accounts caInterimInstant-65000000JPY
Current assetsPrior1YearInstant39631000000JPY
Current assetsInterimInstant37802000000JPY
Buildings and structuresPrior1YearInstant22183000000JPY
Buildings and structuresInterimInstant22256000000JPY
Accumulated depreciation buildings and structuresPrior1YearInstant-16049000000JPY
Accumulated depreciation buildings and structuresInterimInstant-16153000000JPY
Buildings and structures netPrior1YearInstant6133000000JPY
Buildings and structures netInterimInstant6103000000JPY
Machinery equipment and vehiclesPrior1YearInstant26101000000JPY
Machinery equipment and vehiclesInterimInstant26208000000JPY
Accumulated depreciation machinery equipment and vehiclesPrior1YearInstant-22042000000JPY
Accumulated depreciation machinery equipment and vehiclesInterimInstant-21904000000JPY
Machinery equipment and vehicles netPrior1YearInstant4058000000JPY
Machinery equipment and vehicles netInterimInstant4303000000JPY
LandPrior1YearInstant1123000000JPY
LandInterimInstant1101000000JPY
Lease assets ppePrior1YearInstant144000000JPY
Lease assets ppeInterimInstant137000000JPY
Accumulated depreciation lease assets ppePrior1YearInstant-77000000JPY
Accumulated depreciation lease assets ppeInterimInstant-80000000JPY
Lease assets net ppePrior1YearInstant67000000JPY
Lease assets net ppeInterimInstant56000000JPY
Construction in progressPrior1YearInstant5818000000JPY
Construction in progressInterimInstant7746000000JPY
Other ppePrior1YearInstant6564000000JPY
Other ppeInterimInstant6555000000JPY
Accumulated depreciation other ppePrior1YearInstant-5314000000JPY
Accumulated depreciation other ppeInterimInstant-5415000000JPY
Other net ppePrior1YearInstant1250000000JPY
Other net ppeInterimInstant1140000000JPY
Property plant and equipmentPrior1YearInstant18452000000JPY
Property plant and equipmentInterimInstant20452000000JPY
GoodwillPrior1YearInstant1965000000JPY
GoodwillInterimInstant1800000000JPY
Other iaPrior1YearInstant1184000000JPY
Other iaInterimInstant1002000000JPY
Intangible assetsPrior1YearInstant3149000000JPY
Intangible assetsInterimInstant2802000000JPY
Investment securitiesPrior1YearInstant19038000000JPY
Investment securitiesInterimInstant17089000000JPY
Net defined benefit assetPrior1YearInstant2296000000JPY
Net defined benefit assetInterimInstant2332000000JPY
Other ioaPrior1YearInstant1311000000JPY
Other ioaInterimInstant1457000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2025-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass